China NMPA Product Recall - Total Knee Joint System - Zirconium-Niobium Alloy Femoral Condyle

Smith & Nephew, Inc., in conjunction with its subsidiary Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd., has initiated a voluntary Class II recall for its Total Knee System - Zirconium-Niobium Alloy Femoral Implant. This action was officially reported by the National Medical Products Administration (NMPA) on October 24, 2024. The primary reason for the recall is identified product packaging issues originating at the manufacturing facility. The affected medical device, registered under National Medical Device Registration Certificate No. 20153132542, is a critical component for total knee replacement. While the recall details specific models, specifications, and batches in an accompanying report form, the NMPA emphasizes a crucial point: the products implicated in this particular recall were not imported into China. This clarifies that the immediate impact of this specific recall is outside the Chinese market, though the event is documented by the Chinese regulatory body due to the company's operational presence. The Class II designation indicates that while the product may cause temporary or reversible adverse health consequences, the likelihood of serious health risks is remote. This proactive measure by Smith & Nephew demonstrates its commitment to product quality and patient safety, addressing potential packaging integrity concerns.